癌症相关的性内心炎和直接口服抗凝剂:病例报告和系统审查
Glaudir Donato1, Filipe Castor1, João Vitor Andrade Fernandes1
1Center of Medical Sciences, Federal University of Paraíba, João Pessoa, Brazil.
Current cardiology reviews
|August 7, 2025
概括
与癌症相关的非细菌性血栓性内心炎 (NBTE) 的管理仍然具有挑战性. 虽然氨酸有前途,但需要进一步研究用于NBTE治疗的直接口服抗凝剂 (DOAC).
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 非细菌性血栓性内心炎 (NBTE) 的特点是心脏门上的无菌植被,通常与恶性瘤和全身高凝血性有关.
- NBTE经常被低诊断,并带来临床挑战,通常呈现为血栓塞栓事件,如缺血性中风.
研究的目的:
- 报告第一个与癌症相关的NBTE病例,该病例对Rivaroxaban作为维持抗凝药物有反应,并通过3D心声学记录了植被减少的情况.
- 系统地审查直接口服抗凝剂 (DOAC) 在治疗与癌症相关的NBTE的疗效.
主要方法:
- 一个案例研究结合了关于DOAC在与癌症相关的非膜性心房动 (NVAF) 中使用的病例报告的系统审查.
- 在电子数据库中进行文献搜索,然后提取定性数据并对人口统计,临床表现,治疗方法和结果进行分析.
主要成果:
- 包括33项研究. 大多数患者在NBTE诊断之前都在服用DOAC. 肺癌和胰腺癌是最常见的.
- 与DOAC相比,氨酸,特别是低分子量氨酸在植被解决和血栓栓塞事件预防方面表现出更好的结果.
- 使用DOACs有效的NBTE管理与成功控制潜在瘤有关.
结论:
- 建议氨酸更适合治疗与癌症相关的NBTE.
- 进一步的研究是有必要的,以探索在NBTE管理中DOACs的满意结果.
- 通过DOACs成功治疗NBTE似乎取决于有效控制原发性癌症.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:25Endocarditis I: Introduction
26
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
26
01:18Endocarditis III: Medical Management
17
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
17
01:25Endocarditis II: Clinical Features of Infective Endocarditis
25
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
25
01:29Endocarditis IV: Nursing Management
30
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
30
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
909
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
909